<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03167333</url>
  </required_header>
  <id_info>
    <org_study_id>2017-03-009B</org_study_id>
    <nct_id>NCT03167333</nct_id>
  </id_info>
  <brief_title>The Role of Synovitis in Osteoarthritis</brief_title>
  <official_title>Does Synovitis Affect Treatment Efficacy in Intra-articular Injection Therapy to Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Veterans General Hospital, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Veterans General Hospital, Taiwan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether platelet-rich-plasma (PRP) or HA (hyaluronic acid)injection into&#xD;
      synovitis in osteoarthritis(OA) knee can achieve improvement in knee function and reduce&#xD;
      synovitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods:&#xD;
&#xD;
      sixty patients with OA knee having unilateral or bilateral synovitis validated by ultrasound&#xD;
      (N=40) were studied. All the patients were randomized to receive PRP (N=40) or Hyaluronic&#xD;
      acid(HA)(N=40) injection twice at 2-week intervals; Clinical assessments were performed using&#xD;
      a visual analog scale(VAS) and The Western Ontario and McMaster Universities Osteoarthritis&#xD;
      Index (WOMAC index) before injection at baseline, 4 weeks(first evaluation) and 12&#xD;
      weeks(secondary evaluation). Imaging evaluation based on color Doppler ultrasound(CDUS) and&#xD;
      the depth of synovial fluid accumulation ,and the width of synovial hypertrophy was performed&#xD;
      simultaneously.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analog scale(VAS)</measure>
    <time_frame>before injection at baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>visual analog scale(VAS)</measure>
    <time_frame>4 weeks(first evaluation)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>visual analog scale(VAS)</measure>
    <time_frame>12 weeks(secondary evaluation)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC index)</measure>
    <time_frame>before injection at baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC index)</measure>
    <time_frame>4 weeks(first evaluation)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC index)</measure>
    <time_frame>12 weeks(secondary evaluation)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Imaging evaluation based on color Doppler ultrasound(CDUS) and the depth of synovial fluid accumulation ,and the width of synovial hypertrophy was performed simultaneously.</measure>
    <time_frame>before injection at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Imaging evaluation based on color Doppler ultrasound(CDUS) and the depth of synovial fluid accumulation ,and the width of synovial hypertrophy was performed</measure>
    <time_frame>4 weeks(first evaluation)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Imaging evaluation based on color Doppler ultrasound(CDUS) and the depth of synovial fluid accumulation ,and the width of synovial hypertrophy was performed</measure>
    <time_frame>12 weeks(secondary evaluation)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Synovitis of Knee</condition>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the patients received PRP(platelet-rich-plasma) injection twice at 2-week intervals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the patients received HA(hyaluronic acid) injection twice at 2-week intervals</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>platelet rich plasma</intervention_name>
    <description>The amount of PPR was about 4-5 cc</description>
    <arm_group_label>PRP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyaluronic acid</intervention_name>
    <description>HA was 2.5cc</description>
    <arm_group_label>HA group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosed with OA knee according to ACR guideline&#xD;
&#xD;
               1. stiffness less than 30min&#xD;
&#xD;
               2. cracking sound during activity&#xD;
&#xD;
               3. more than 30min pain for last 2 months&#xD;
&#xD;
               4. non-bed ridden patients&#xD;
&#xD;
               5. no structure abnormality&#xD;
&#xD;
               6. synovitis was proved by US&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. OA knee secondary to other disease 2 . more than 10 years after diagnosing OA 3. under&#xD;
        knee surgery within 3 months 4. autoimmune disease 5. refuses inform/consent process&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chien-CHIh Wang, MD</last_name>
    <phone>886-958738258</phone>
    <email>candycandywang@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taipei veteran general hospital yuli branch</name>
      <address>
        <city>Hualien City</city>
        <zip>886</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chien-Chih Wang</last_name>
      <phone>886 958738258</phone>
      <email>candycandywang@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 18, 2017</study_first_submitted>
  <study_first_submitted_qc>May 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2017</study_first_posted>
  <last_update_submitted>February 9, 2020</last_update_submitted>
  <last_update_submitted_qc>February 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Synovitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

